April 3, 2020
March 31, 2020
March 27, 2020
March 20, 2020
The quarterly use and expenditure pattern reports provide prescription drug use and expenditure information for the most prescribed individual drugs and therapeutic drug classes.
March 17, 2020
March 11, 2020
March 2, 2020
Our drug shortage notification process is available for pharmacy staff to notify HHSC about potential drug shortages that impact prescribing choice and pharmacy claim processing
February 26, 2020
February 21, 2020
February 14, 2020
February 7, 2020
The Texas Drug Utilization Review Board met recently to make recommendations about clinical prior authorizations and the preferred drug list.
January 23, 2020
January 17, 2020
VDP will modify the Austedo prior authorization criteria on March 3. The criteria are included within the existing Vesicular Monoamine Transporter 2 (VMAT2) Inhibitors criteria guide. The class includes Austedo, Xenazine and Ingrezza.